Top news of the week: 05.01.2021.
Coronavirus
China gives its first COVID-19 vaccine approval to Sinopharm
China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater ...
U.S. COVID-19 cases surpass 20 million as deaths mount
U.S. coronavirus cases crossed the 20 million mark on Friday as officials seek to speed up vaccinations and a more infectious variant surfaces in Colorado, California and Florida.
China Sinopharm’s vaccine has 79.34% protection rate against COVID-19
A COVID-19 vaccine developed by a Beijing firm linked to Sinopharm has a protection rate of 79.34% against the disease, the firm said in a statement on Wednesday.
China gives conditional approval to Sinopharm COVID-19 vaccine
China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, making it the country's first approved shot for general public use, ...
‘It’s crazy.’ Upbeat COVID-19 vaccine news from China and U.K. leaves scientists wanting more details
Sinopharm efficacy news, British dosing schedule leave questions
Interview: China-developed COVID-19 vaccine effective, safe -- Egyptian official
A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co., Ltd. (Sinopharm) in Beijing, capital …
U.S. media say China's COVID-19 strategy "more targeted"
A medical worker disinfects a transfer vehicle in Shunyi District of Beijing, capital of China, Dec. 31, 2020. (Xinhua/Chen Zhonghao) The local government of Beijing "has …
Across China: Chinese celebrate New Year despite sporadic COVID-19 outbreaks
A grand national flag-raising ceremony is held as part of the celebrations for the New Year's Day at the Tian'anmen Square in Beijing, capital of China, Jan. 1, 2021. (Xinhua/Ren …